谢春光教授从虚与瘀论治非增殖期糖尿病视网膜病变经验
|
摘要
谢春光教授是四川省名中医、博士生导师,从事糖尿病临床与科研工作30余年,对糖尿病及其并发症有独到见解。谢春光教授认为非增殖期糖尿病视网膜病变的基本病因病机是气阴两虚为本、络脉瘀阻为标,论治以养阴益气活血法为主,遣药参芪复方为基础加减,临证专方专病,灵活加减,取效良好。
Professor XIE Chunguang is a famous Chinese medicine practitioner who has been engaged in clinical work for many years and has unique insights into diabetes and its complications. In the treatment of complications,Professor XIE Chunguang believes that the basic etiology and pathogenesis of non-proliferative diabetic retinopathy is Qi and Yin deficiency and collaterals. The treatment method is to nourish Yin and Qi and promote blood circulation. The prescription is added to or subtracted from the Shenfu Compound. Specialized disease and flexible application make the clinical effect better.
Professor XIE Chunguang is a famous Chinese medicine practitioner who has been engaged in clinical work for many years and has unique insights into diabetes and its complications. In the treatment of complications,Professor XIE Chunguang believes that the basic etiology and pathogenesis of non-proliferative diabetic retinopathy is Qi and Yin deficiency and collaterals. The treatment method is to nourish Yin and Qi and promote blood circulation. The prescription is added to or subtracted from the Shenfu Compound. Specialized disease and flexible application make the clinical effect better.
引文
[1] International Diabetes Federation. IDF DIABETES ATLAS-8THEDITION[EB/OL]:http://www. diabetesatlas. org/
[2]中华医学会眼科学会眼底病学组.我国糖尿病性视网膜病变临床诊疗指南(2014)[J].中华眼科杂志,2014,50(11):851~865
[3]魏玲玲,李秋贵. 2型糖尿病视网膜病变患者中医证型与实验室指标的关系[J].中医杂志,2011,52(20):1759~1762
[4]侯宇辉,魏莹.非增殖期糖尿病视网膜病变中医证型研究[J].中医临床研究,2016,8(7):5~7
[5] Pusparajah P,Lee LH,Kadir KA. Molecular Markers of Dia-betic Retinopathy:Potential Screening Tool of the Future[J]. Front Phys-iol,2016,7:200
[6] Wan TT,Li XF,Sun YM,et al. Recent advances in under-standing the biochemical and molecular mechanism of diabetic retinopathy[J]. Biomed Pharmacother,2015,74:145~147
[7]岳宗相,王艳红,刘致勤,等.参芪复方对糖尿病血管氧化应激相关蛋白表达的影响[J].世界中西医结合杂志,2013,8(11):1156~1159,1174
[8]张琨,谢春光.参芪复方对GK大鼠2型糖尿病大血管病变氧化应激的影响[J].中华中医药杂志,2012,27(4):1084~1088
[9]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠炎症标志物的影响及机理探讨[J].中药材,2006,29(3):249~253
[10]陈敏,高泓,谢春光,等.参芪复方对GK大鼠主动脉COX-2mRNA表达的影响[J].中华中医药杂志,2010,25(9):1459~1461
[11]谢红艳,李天浩,谢春光.参芪复方对改善糖尿病血管病变患者IL-6、hs-CRP的临床研究[J].中医临床研究,2015,35(7):64~65
[12]殷丽平,杜联,谢春光,等.参芪复方对实验性2型糖尿病大血管病变胰岛素抵抗的干预作用[J].成都中医药大学学报,2010,33(3):54~56
[13]呼永河,侯君,郑德志,等.参芪复方对糖尿病模型大鼠血管病变的保护作用及机制[J].中国中西医结合杂志,2014,34(9):1078~1084
[14]覃海知,郭保根,富晓旭,等.参芪复方调控差异基因对血管内皮保护作用的实验研究[J].中华中医药杂志,2017,32(2):750~753
[2]中华医学会眼科学会眼底病学组.我国糖尿病性视网膜病变临床诊疗指南(2014)[J].中华眼科杂志,2014,50(11):851~865
[3]魏玲玲,李秋贵. 2型糖尿病视网膜病变患者中医证型与实验室指标的关系[J].中医杂志,2011,52(20):1759~1762
[4]侯宇辉,魏莹.非增殖期糖尿病视网膜病变中医证型研究[J].中医临床研究,2016,8(7):5~7
[5] Pusparajah P,Lee LH,Kadir KA. Molecular Markers of Dia-betic Retinopathy:Potential Screening Tool of the Future[J]. Front Phys-iol,2016,7:200
[6] Wan TT,Li XF,Sun YM,et al. Recent advances in under-standing the biochemical and molecular mechanism of diabetic retinopathy[J]. Biomed Pharmacother,2015,74:145~147
[7]岳宗相,王艳红,刘致勤,等.参芪复方对糖尿病血管氧化应激相关蛋白表达的影响[J].世界中西医结合杂志,2013,8(11):1156~1159,1174
[8]张琨,谢春光.参芪复方对GK大鼠2型糖尿病大血管病变氧化应激的影响[J].中华中医药杂志,2012,27(4):1084~1088
[9]张红敏,陈世伟,谢春光,等.参芪复方对GK大鼠炎症标志物的影响及机理探讨[J].中药材,2006,29(3):249~253
[10]陈敏,高泓,谢春光,等.参芪复方对GK大鼠主动脉COX-2mRNA表达的影响[J].中华中医药杂志,2010,25(9):1459~1461
[11]谢红艳,李天浩,谢春光.参芪复方对改善糖尿病血管病变患者IL-6、hs-CRP的临床研究[J].中医临床研究,2015,35(7):64~65
[12]殷丽平,杜联,谢春光,等.参芪复方对实验性2型糖尿病大血管病变胰岛素抵抗的干预作用[J].成都中医药大学学报,2010,33(3):54~56
[13]呼永河,侯君,郑德志,等.参芪复方对糖尿病模型大鼠血管病变的保护作用及机制[J].中国中西医结合杂志,2014,34(9):1078~1084
[14]覃海知,郭保根,富晓旭,等.参芪复方调控差异基因对血管内皮保护作用的实验研究[J].中华中医药杂志,2017,32(2):750~753